PassPort Technologies Commences Collaborative Research with Arcturus Therapeutics to Evaluate Transdermal mRNA delivery systems ...Middle East

Arcturus's mRNA medicines and vaccines and lipid-mediated drug delivery systems in combination with PassPort's innovative transdermal drug delivery system. SAN DIEGO, Jan. 5, 2024 /PRNewswire/ -- PassPort Technologies, Inc. (PPTI), led by President and CEO Tomoyuki Fujisawa in California,...

Hence then, the article about passport technologies commences collaborative research with arcturus therapeutics to evaluate transdermal mrna delivery systems was published today ( Friday 05/01/2024 - 09:25 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PassPort Technologies Commences Collaborative Research with Arcturus Therapeutics to Evaluate Transdermal mRNA delivery systems )

Also on site :

• Mountain lion spotted in San Francisco's Pacific Heights neighborhood
• France to ditch American video conferencing services
• Sydney Sweeney gives first look at forthcoming lingerie brand, Syrn, in black lace